Read the full press release from PRNewswire here. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company’s commercial […]

Read the full story from the Wisconsin State Journal here. A Madison-based diagnostics company wants to make testing for the COVID-19 coronavirus easier and quicker for patients and health care providers. GoDx has been developing paper-based tests for pathogens that cause gastrointestinal diseases, such as salmonella and norovirus. While those tests are currently undergoing clinical […]

Read the full story from WISCONSININNO. Madison-based Nimble Therapeutics, a fairly new company that was spun out from Switzerland-based F. Hoffmann-La Roche, is collaborating with Roche Diagnostics to discover and develop novel peptide-based molecules for diagnostics of SARS-CoV-2, the virus that causes COVID-19. Nimble Therapeutics is developing a chemical synthesis technology for drug development. The […]

Read the full press release from BioSpace here. Arcturus Therapeutics, Inc. Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health […]